Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812253 · ClinicalTrials.gov registry record · Phase 2
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
A Phase 2 study, sponsored by Kathleen Dungan.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT00812253: Completed Phase 2 study, sponsored by Kathleen Dungan.
NCT00812253 is a Phase 2 study that has completed, run by Kathleen Dungan. The registered enrollment target is 74 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812253, a Phase 2 study, has completed, sponsored by Kathleen Dungan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
Patients with heart failure often have high blood sugar (glucose).
Primary Outcome
Duration of hospitalization in days
Interventions
- DRUG Intravenous insulin
- DRUG Subcutaneous insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-05 |
| Phase | Phase 2 |
What the finished NCT00812253 record still lists
NCT00812253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 2 interventions - of which Intravenous insulin is the first listed.
NCT00812253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00812253 about?
NCT00812253 is a clinical study titled "Intensive Glycemic Control for Congestive Heart Failure Exacerbation". Patients with heart failure often have high blood sugar (glucose).
What is the current status of trial NCT00812253?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2009-01. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00812253?
The interventions under investigation include: Intravenous insulin (DRUG), Subcutaneous insulin (DRUG).
Who is sponsoring clinical trial NCT00812253?
This trial is sponsored by Kathleen Dungan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00812253's enrollment target sits among peer trials
74 920th of 2000 higher than 1,077 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia